2nd Quarter - Report

NVG, LLC for ALEXION PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Orphan Drug Act

LobbyistCovered position, as disclosed
ANDREA LARUE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

FDA - rare and orphan disease issues; 21st Century CURES

LobbyistCovered position, as disclosed
LISA GERMAN FOSTER —
ANDREA LARUE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

The Innovation Act (H.R. 9; S. 1137); General issues related to intellectual property and potential changes to the patent system

LobbyistCovered position, as disclosed
ANDREA LARUE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1137 (114th), H.R. 9 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.